- Home
- NET vs GEHC Comparison
NET vs GEHC Comparison
Compare NET & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NET
- GEHC
- Stock Information
- Founded
- NET 2009
- GEHC 1892
- Country
- NET United States
- GEHC United States
- Employees
- NET N/A
- GEHC N/A
- Industry
- NET Computer Software: Prepackaged Software
- GEHC Computer Software: Prepackaged Software
- Sector
- NET Technology
- GEHC Technology
- Exchange
- NET Nasdaq
- GEHC Nasdaq
- Market Cap
- NET 39.7B
- GEHC 36.2B
- IPO Year
- NET 2019
- GEHC N/A
- Fundamental
- Price
- NET $119.85
- GEHC $87.34
- Analyst Decision
- NET Buy
- GEHC Buy
- Analyst Count
- NET 26
- GEHC 14
- Target Price
- NET $107.44
- GEHC $96.00
- AVG Volume (30 Days)
- NET 2.5M
- GEHC 3.2M
- Earning Date
- NET 02-06-2025
- GEHC 02-13-2025
- Dividend Yield
- NET N/A
- GEHC 0.16%
- EPS Growth
- NET N/A
- GEHC 8.27
- EPS
- NET N/A
- GEHC 3.65
- Revenue
- NET $1,572,153,000.00
- GEHC $19,559,000,000.00
- Revenue This Year
- NET $29.40
- GEHC $2.70
- Revenue Next Year
- NET $25.74
- GEHC $3.90
- P/E Ratio
- NET N/A
- GEHC $23.93
- Revenue Growth
- NET 30.04
- GEHC 1.43
- 52 Week Low
- NET $66.24
- GEHC $71.31
- 52 Week High
- NET $121.02
- GEHC $94.55
- Technical
- Relative Strength Index (RSI)
- NET 65.28
- GEHC 66.03
- Support Level
- NET $108.59
- GEHC $82.86
- Resistance Level
- NET $121.02
- GEHC $86.25
- Average True Range (ATR)
- NET 3.24
- GEHC 2.06
- MACD
- NET 0.16
- GEHC 0.68
- Stochastic Oscillator
- NET 91.63
- GEHC 97.21
About NET Cloudflare Inc.
Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, leverages this network by providing clients the ability to deploy, and execute code without maintaining servers.
About GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (54% of revenue), ultrasound (18%), patient care solutions (16%), and pharmaceutical diagnostics (12%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 44%, 26%, 14%, and 16% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (33% of revenue), pharmaceutical diagnostics (12%), and digital solutions (6%).